prostate cancer
Item
histologically confirmed stage ii prostate cancer
boolean
C0600139 (UMLS CUI [1,1])
C0441767 (UMLS CUI [1,2])
tumor stage
Item
t1b-c, n0, m0 with prostate-specific antigen (psa) at least 10 ng/ml and/or gleason score at least 7 (uicc 1997 classification) or
boolean
C0475385 (UMLS CUI [1])
C0475386 (UMLS CUI [2])
C0138741 (UMLS CUI [3])
T2a
Item
t2a, n0, m0 (uicc 1997 classification)
boolean
C0475387 (UMLS CUI [1])
serum psa
Item
serum psa no greater than 50 ng/ml
boolean
C2123607 (UMLS CUI [1])
involvement of pelvic lymph nodes
Item
no involvement of pelvic lymph nodes
boolean
C0729595 (UMLS CUI [1,1])
C0475437 (UMLS CUI [1,2])
age
Item
age: 80 and under
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status: who 0-2
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy: not specified
boolean
C0023671 (UMLS CUI [1])
hematopoietic
Item
hematopoietic: not specified
boolean
C0229601 (UMLS CUI [1])
hepatic
Item
hepatic: not specified
boolean
C0205054 (UMLS CUI [1])
renal
Item
renal: not specified
boolean
C0022646 (UMLS CUI [1])
no other malignancy
Item
no other malignancy within the past 5 years except adequately treated basal cell skin cancer
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
comorbidities
Item
no psychological, familial, sociological, or geographical condition that would preclude study participation
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
biologic therapy
Item
biologic therapy: not specified
boolean
C0005527 (UMLS CUI [1])
chemotherapy
Item
chemotherapy: not specified
boolean
C0392920 (UMLS CUI [1])
hormonal therapy
Item
endocrine therapy: no prior hormonal therapy
boolean
C0279025 (UMLS CUI [1])
pelvic radiotherapy
Item
radiotherapy: no prior pelvic radiotherapy
boolean
C1522449 (UMLS CUI [1])
radical prostatectomy
Item
surgery: no prior radical prostatectomy
boolean
C0194810 (UMLS CUI [1])